Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-11-000489
Filing Date
2011-08-17
Accepted
2011-08-17 12:31:53
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 369843
2 GRAPHIC1 image_001.jpg GRAPHIC 3687
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 43773
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 9084
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 8990
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 4825
  Complete submission text file 0001255294-11-000489.txt   1379445

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE oprx-20110630.xml EX-101.INS 120353
8 XBRL SCHEMA FILE oprx-20110630.xsd EX-101.SCH 8566
9 XBRL DEFINITION FILE oprx-20110630_def.xml EX-101.DEF 3782
10 XBRL LABEL FILE oprx-20110630_lab.xml EX-101.LAB 82888
11 XBRL PRESENTATION FILE oprx-20110630_pre.xml EX-101.PRE 57426
Mailing Address 407 SIXTH STREET ROCHESTER MI 48307
Business Address 407 SIXTH STREET ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53605 | Film No.: 111041896
SIC: 7389 Services-Business Services, NEC